Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MSR1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | FBXO2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | VIMP | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | CFLAR | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | SDHAF1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | HIST2H2AA4 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | BARHL1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | CDR1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | SLC51A | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | FMO5 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |